The evolution of INFARMED-licensed companies in Portugal tells a story of strategic regulatory execution. In less than a decade, the country has built a pharmaceutical cannabis sector from zero to one of the largest and most robust in Europe, second only to Canada in global exports . For pharmaceutical industry professionals, Portugal represents a case study in how regulatory clarity—combined with a focus on GMP compliance and export infrastructure—can create a sustainable and globally relevant medical cannabis market.
Free PDF Download
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link
Also see:
Manostaxx – Industrial Management Consulting
